Trial · NCT00500071
Results by group14
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 14 of 14
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Weekly Change From Baseline in Total ADHD-RS-IV Score | Vyvanse | Week 1 | -11.3 | Standard Error 0.62 | Units on a scale |
| Weekly Change From Baseline in Total ADHD-RS-IV Score | Vyvanse | Week 2 | -17.8 | Standard Error 0.63 | Units on a scale |
| Weekly Change From Baseline in Total ADHD-RS-IV Score | Vyvanse | Week 3 | -21.7 | Standard Error 0.61 | Units on a scale |
| Weekly Change From Baseline in Total ADHD-RS-IV Score | Vyvanse | Week 4 | -25.4 | Standard Error 0.61 | Units on a scale |
| Weekly Change From Baseline in Total ADHD-RS-IV Score | Vyvanse | Week 5 | -27.0 | Standard Error 0.60 | Units on a scale |
| Weekly Change From Baseline in Total ADHD-RS-IV Score | Vyvanse | Week 6 | -28.9 | Standard Error 0.60 | Units on a scale |
| Weekly Change From Baseline in Total ADHD-RS-IV Score | Vyvanse | Week 7 | -29.8 | Standard Error 0.58 | Units on a scale |
| Change From Baseline in Total Attention Deficit Hyperactivity Disorder Rating Scale-fourth Edition (ADHD-RS-IV) Score at 7 Weeks | Vyvanse | -28.6 | Standard Error 0.61 | Units on a scale | |
| Number of Participants With Improvement on Clinical Global Impression-Improvement (CGI-I) | Vyvanse | 284 | Participants | ||
| Number of Participants With Improvement onParent Global Assessment (PGA) | Vyvanse | 267 | Participants | ||
| Change From Baseline in Expression and Emotional Scale for Children (EESC) Scores at 7 Weeks | Vyvanse | -7.4 | Standard Deviation 18.3 | Units on a scale | |
| Changes From Baseline in Behavior Rating Inventory of Executive Function (BRIEF) Scores at 7 Weeks | Vyvanse | Global Executive Composite | -17.9 | Standard Deviation 12.5 | Units on a scale |
| Changes From Baseline in Behavior Rating Inventory of Executive Function (BRIEF) Scores at 7 Weeks | Vyvanse | Behavioral Recognition Index | -15.4 | Standard Deviation 12.6 | Units on a scale |
| Changes From Baseline in Behavior Rating Inventory of Executive Function (BRIEF) Scores at 7 Weeks | Vyvanse | Metacognition Index | -17.6 | Standard Deviation 12.3 | Units on a scale |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00500071/results